Advanced
  Home Compare Reports

Comparison with Similar Reports

Veterinary Infectious Disease Diagnostics Market by Technology (Immunodiagnostics, Molecular Diagnostics (PCR)), Animal (Companion, Food-producing ani...

Publisher:        MarketsandMarkets

# of Pages:        379

Rating: 

1 User License $4,950

Publication Date:  February, 2022

Price:       $4,950 / User License




1 INTRODUCTION 41
1.1 OBJECTIVES OF THE STUDY 41
1.2 MARKET DEFINITION & SCOPE 41
1.2.1 INCLUSIONS & EXCLUSIONS 41
1.2.2 MARKET SEGMENTATION 42
FIGURE 1 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SEGMENTATION 42
1.2.3 YEARS CONSIDERED FOR THE STUDY 43
1.3 CURRENCY 43
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 43
1.4 STAKEHOLDERS 44
1.5 SUMMARY OF CHANGES 44
2 RESEARCH METHODOLOGY 46
2.1 RESEARCH DATA 46
FIGURE 2 RESEARCH DESIGN 46
2.1.1 SECONDARY DATA 47
2.1.1.1 Key data from secondary sources 48
2.1.2 PRIMARY DATA 48
FIGURE 3 PRIMARY SOURCES 48
2.1.2.1 Key data from primary sources 49
2.1.2.2 Insights from primary experts 50
2.1.2.3 Key industry insights 50
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 50
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE PARTICIPANTS,
BY COMPANY TYPE, DESIGNATION, AND REGION 51
FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS: DEMAND-SIDE PARTICIPANTS,
BY END USER, DESIGNATION, AND REGION 51
2.2 MARKET SIZE ESTIMATION 52
FIGURE 7 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 52
FIGURE 8 REVENUE SHARE ANALYSIS ILLUSTRATION: IDEXX LABORATORIES, INC. 53
FIGURE 9 SUPPLY-SIDE ANALYSIS OF THE TOP COMPANIES: COMPANION DIAGNOSTICS MARKET (2020) 53
FIGURE 10 SUPPLY-SIDE ANALYSIS OF THE TOP COMPANIES: FOOD-PRODUCING ANIMALS DIAGNOSTICS MARKET (2020) 54
FIGURE 11 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET (2021–2026) 55
FIGURE 12 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 56
FIGURE 13 TOP-DOWN APPROACH 56
 
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 57
FIGURE 14 MARKET DATA TRIANGULATION METHODOLOGY 57
2.4 MARKET SHARE ANALYSIS 58
2.5 ASSUMPTIONS FOR THE STUDY 58
2.6 LIMITATIONS 58
2.7 RISK ASSESSMENT 59
TABLE 2 RISK ASSESSMENT: VETERINARY INFECTIOUS DISEASE
DIAGNOSTICS MARKET 59
3 EXECUTIVE SUMMARY 60
FIGURE 15 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021 VS. 2026 (USD MILLION) 60
FIGURE 16 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021 VS. 2026 (USD MILLION) 61
FIGURE 17 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2021 VS. 2026 (USD MILLION) 61
FIGURE 18 GEOGRAPHICAL SNAPSHOT OF THE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET 62
4 PREMIUM INSIGHTS 64
4.1 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET OVERVIEW 64
FIGURE 19 GROWING PREVALENCE OF ZOONOTIC DISEASES TO DRIVE
THE MARKET GROWTH 64
4.2 ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER AND COUNTRY (2020) 65
FIGURE 20 THE VETERINARY REFERENCE LABORATORIES SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE APAC MARKET IN 2020 65
4.3 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 66
FIGURE 21 ASIA PACIFIC TO REGISTER THE HIGHEST GROWTH IN THE GLOBAL MARKET DURING THE FORECAST PERIOD 66
4.4 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY REGION (2019–2026) 67
FIGURE 22 NORTH AMERICA WILL CONTINUE TO DOMINATE THE MARKET DURING THE FORECAST PERIOD 67
4.5 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: DEVELOPED VS. DEVELOPING MARKETS 67
FIGURE 23 DEVELOPING MARKETS TO REGISTER A HIGHER GROWTH RATE DURING THE FORECAST PERIOD 67
5 MARKET OVERVIEW 68
5.1 INTRODUCTION 68
5.2 MARKET DYNAMICS 68
FIGURE 24 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 68
5.2.1 MARKET DRIVERS 69
5.2.1.1 Rising demand for animal-derived food products 69
TABLE 3 PAST AND PROJECTED TRENDS IN THE CONSUMPTION OF MEAT & MILK IN DEVELOPED AND DEVELOPING COUNTRIES 69
TABLE 4 ASIA: COUNTRY-LEVEL CONSUMPTION OF ANIMAL-DERIVED FOOD PRODUCTS, 2020 VS. 2030 (THOUSAND METRIC TONS) 70
FIGURE 25 ASIA WAS THE HIGHEST CONSUMER OF MEAT AND MILK IN 2018 70
5.2.1.2 Increasing companion animal population 71
5.2.1.3 Rising demand for pet insurance and the subsequent growth in animal health expenditure 71
TABLE 5 AVERAGE PREMIUMS PAID IN THE US, 2019 VS. 2020 72
FIGURE 26 US: PET INDUSTRY EXPENDITURE, 2010–2019 72
5.2.1.4 Growing number of veterinary practitioners in developed economies 73
TABLE 6 NUMBER OF VETERINARIANS AND PARAVETERINARIANS IN DEVELOPED COUNTRIES, 2012–2018 73
5.2.1.5 Increasing disease control & disease prevention measures 73
5.2.1.6 Rising incidence of transboundary & zoonotic diseases 74
TABLE 7 ANIMAL DISEASE OUTBREAKS IN ASIA PACIFIC COUNTRIES (2009–2019) 74
5.2.1.7 Growing demand for advanced diagnostic devices 75
5.2.2 MARKET RESTRAINTS 76
5.2.2.1 Rising pet care costs 76
5.2.2.2 High costs of veterinary diagnostic tests 77
5.2.3 MARKET OPPORTUNITIES 77
5.2.3.1 Increasing use of PCR-testing panels for COVID-19 testing in animals 77
5.2.3.2 Untapped emerging economies 78
5.2.4 MARKET CHALLENGES 78
5.2.4.1 Shortage of veterinary practitioners in developing markets 78
5.2.4.2 Lack of animal healthcare awareness in emerging countries 79
TABLE 8 NUMBER OF VETERINARY PROFESSIONALS, BY COUNTRY,
2005 VS. 2014 VS. 2018 79
5.3 IMPACT OF COVID-19 ON THE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET 80
TABLE 9 GLOBAL SNAPSHOT OF THE REPORTED CASES OF NATURALLY ACQUIRED SARS- COV-2 (COVID-19) INFECTIONS IN ANIMALS 80
FIGURE 27 MONTHLY VETERINARY PRACTICE ACTIVITY, BY REGION,
JANUARY–JUNE 2020 81
5.4 INDUSTRY TRENDS 81
5.4.1 RISING VEGAN POPULATION 81
5.4.2 ADOPTION OF WEB MONITORING AND OTHER DIGITAL AIDS TO DETECT EMERGING INFECTIOUS DISEASES IN ANIMALS 82
5.4.3 EXPANSIVE GROWTH IN VETERINARY BUSINESSES 82
5.5 VALUE CHAIN ANALYSIS 83
FIGURE 28 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: VALUE CHAIN ANALYSIS 83
5.6 ECOSYSTEM MARKET MAP 83
FIGURE 29 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: ECOSYSTEM PARTICIPANTS 84
FIGURE 30 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET:
ECOSYSTEM MARKET 84
5.7 PORTER’S FIVE FORCES ANALYSIS 85
TABLE 10 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: PORTER’S FIVE FORCES ANALYSIS 85
5.7.1 THREAT OF NEW ENTRANTS 85
5.7.2 THREAT OF SUBSTITUTES 86
5.7.3 BARGAINING POWER OF SUPPLIERS 86
5.7.4 BARGAINING POWER OF BUYERS 86
5.7.5 INTENSITY OF COMPETITIVE RIVALRY 86
5.8 PRICING ANALYSIS 87
TABLE 11 REGIONAL PRICING ANALYSIS OF VETERINARY ANALYZERS, 2021 (USD) 87
5.9 PATENT ANALYSIS 87
5.9.1 PATENT PUBLICATION TRENDS FOR VETERINARY DIAGNOSTICS 88
5.9.2 PATENT PUBLICATION TRENDS (2011–DECEMBER 2021) 88
5.9.3 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 88
FIGURE 31 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR VETERINARY INFECTIOUS DISEASE DIAGNOSTIC PATENTS (JANUARY
2011–DECEMBER 2021) 89
FIGURE 32 TOP APPLICANT COUNTRIES/REGIONS FOR VETERINARY INFECTIOUS DISEASE DIAGNOSTICS PATENTS (JANUARY 2011–DECEMBER 2021) 90
5.10 TECHNOLOGICAL ANALYSIS 90
5.10.1 KEY TECHNOLOGY 90
5.10.1.1 Development of portable instruments for POC diagnostic services 90
TABLE 12 PONT-OF-CARE PORTABLE VETERINARY DIAGNOSTIC INSTRUMENTS 90
5.10.2 ADJACENT TECHNOLOGY 91
5.10.2.1 Development of rapid and sensitive veterinary diagnostic kits 91
6 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY 92
6.1 INTRODUCTION 93
TABLE 13 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION) 93
6.2 IMMUNODIAGNOSTICS 93
TABLE 14 KEY VETERINARY IMMUNODIAGNOSTIC PRODUCTS AVAILABLE IN THE MARKET 94
TABLE 15 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2019–2026 (USD MILLION) 95
TABLE 16 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY COUNTRY, 2019–2026 (USD MILLION) 95
6.2.1 LATERAL FLOW ASSAYS 96
6.2.1.1 Lateral flow assays offer rapid results & accurate diagnosis 96
TABLE 17 LATERAL FLOW ASSAYS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 97
6.2.2 ELISA TESTS 97
6.2.2.1 ELISA tests have gained widespread popularity in the market owing to their efficacy and accurate validation of results 97
TABLE 18 ELISA TESTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 98
6.2.3 OTHER IMMUNODIAGNOSTIC PRODUCTS 98
TABLE 19 OTHER IMMUNODIAGNOSTIC PRODUCTS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 99
6.3 MOLECULAR DIAGNOSTICS 99
TABLE 20 KEY VETERINARY MOLECULAR DIAGNOSTICS PRODUCTS
AVAILABLE IN THE MARKET 100
TABLE 21 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2019–2026 (USD MILLION) 101
TABLE 22 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY COUNTRY, 2019–2026 (USD MILLION) 101
6.3.1 POLYMERASE CHAIN REACTION (PCR) TESTS 102
6.3.1.1 PCR is an effective tool for the diagnosis of diseases in food-producing animals and companion animals 102
TABLE 23 PCR TESTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 102
6.3.2 MICROARRAYS 103
6.3.2.1 Technological advancements and the increasing incidence of infectious diseases are factors supporting the growth of this market 103
TABLE 24 MICROARRAYS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 103
6.3.3 OTHER MOLECULAR DIAGNOSTIC PRODUCTS 104
TABLE 25 OTHER MOLECULAR DIAGNOSTIC PRODUCTS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 104
6.4 OTHER TECHNOLOGIES 105
TABLE 26 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2019–2026 (USD MILLION) 105
7 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE 106
7.1 INTRODUCTION 107
TABLE 27 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION) 107
7.2 COMPANION ANIMALS 107
TABLE 28 POPULATION OF COMPANION ANIMALS, BY COUNTRY,
2012–2019 (MILLION) 108
TABLE 29 INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS,
BY ANIMAL TYPE, 2019–2026 (USD MILLION) 108
TABLE 30 INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS,
BY COUNTRY, 2019–2026 (USD MILLION) 109
7.2.1 DOGS 109
7.2.1.1 The pet dog population has grown significantly in recent years 109
TABLE 31 SOME OF THE MAJOR ZOONOTIC DISEASES AFFECTING DOGS 110
TABLE 32 SOME OF THE MAJOR INFECTIOUS DISEASES AFFECTING DOGS 110
TABLE 33 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR DOGS,
BY COUNTRY, 2019–2026 (USD MILLION) 114
7.2.2 CATS 115
7.2.2.1 Increasing pet cat population to drive the market growth 115
TABLE 34 SOME OF THE MAJOR ZOONOTIC DISEASES AFFECTING CATS 115
TABLE 35 SOME OF THE MAJOR INFECTIOUS DISEASES AFFECTING CATS 115
TABLE 36 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR CATS,
BY COUNTRY, 2019–2026 (USD MILLION) 119
7.2.3 HORSES 119
7.2.3.1 Research programs on horse health awareness is a major factor driving the demand for infection diagnostics for this segment 119
TABLE 37 HORSE POPULATION, BY REGION, 2014–2017 (USD MILLION) 120
TABLE 38 SOME OF THE MAJOR ZOONOTIC DISEASES AFFECTING HORSES 120
TABLE 39 SOME OF THE MAJOR INFECTIOUS DISEASES AFFECTING HORSES 121
TABLE 40 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR HORSES,
BY COUNTRY, 2019–2026 (USD MILLION) 124
7.2.4 OTHER COMPANION ANIMALS 124
TABLE 41 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR OTHER COMPANION ANIMALS, BY COUNTRY, 2019–2026 (USD MILLION) 125
7.2.5 INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS,
BY INFECTION TYPE 125
TABLE 42 INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS,
BY INFECTION TYPE, 2019–2026 (USD MILLION) 126
7.2.5.1 Viral infections 126
7.2.5.1.1 The highly contagious nature of viral diseases is a major factor driving the demand for infection diagnostics in companion animals 126
TABLE 43 PRODUCTS OFFERED FOR THE DIAGNOSIS OF VIRAL INFECTIONS IN COMPANION ANIMALS 127
TABLE 44 VIRAL DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS,
BY REGION, 2019–2026 (USD MILLION) 128
7.2.5.2 Bacterial infections 128
7.2.5.2.1 The bacterial infections segment accounted for the largest share of the market in 2020 128
TABLE 45 PRODUCTS OFFERED FOR THE DIAGNOSIS OF BACTERIAL INFECTIONS IN COMPANION ANIMALS 129
TABLE 46 BACTERIAL DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS,
BY REGION, 2019–2026 (USD MILLION) 130
7.2.5.3 Parasitic infections 130
7.2.5.3.1 Rising incidence of worm infestation in companion animals to support the growth of this market 130
TABLE 47 PRODUCTS OFFERED FOR THE DIAGNOSIS OF PARASITIC INFECTIONS IN COMPANION ANIMALS 131
TABLE 48 PARASITIC DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS,
BY REGION, 2019–2026 (USD MILLION) 132
7.2.5.4 Other infections 132
TABLE 49 PRODUCTS OFFERED FOR THE DIAGNOSIS OF FUNGAL INFECTIONS IN COMPANION ANIMALS 133
TABLE 50 PRODUCTS OFFERED FOR THE DIAGNOSIS OF OTHER INFECTIONS IN COMPANION ANIMALS 133
TABLE 51 OTHER INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY REGION, 2019–2026 (USD MILLION) 133
 
7.3 FOOD-PRODUCING ANIMALS 134
7.3.1 INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY ANIMAL TYPE 134
TABLE 52 POPULATION OF FOOD-PRODUCING ANIMALS IN THE US,
2012 TO 2019 (MILLION) 134
TABLE 53 INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY ANIMAL TYPE, 2019–2026 (USD MILLION) 134
TABLE 54 INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY COUNTRY, 2019–2026 (USD MILLION) 135
7.3.1.1 Cattle 135
7.3.1.1.1 Growing demand for meat & dairy products to support the growth of this segment 135
TABLE 55 SOME OF THE MAJOR ZOONOTIC DISEASES AFFECTING CATTLE 136
TABLE 56 SOME OF THE MAJOR INFECTIOUS DISEASES AFFECTING CATTLE 136
TABLE 57 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR CATTLE,
BY COUNTRY, 2019–2026 (USD MILLION) 139
7.3.1.2 Swine 139
7.3.1.2.1 Extensive use of infectious disease diagnostics as a response to epidemic outbreaks in this segment 139
TABLE 58 SOME OF THE MAJOR ZOONOTIC DISEASES AFFECTING SWINE 140
TABLE 59 SOME OF THE MAJOR INFECTIOUS DISEASES AFFECTING SWINE 140
TABLE 60 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR SWINE,
BY COUNTRY, 2019–2026 (USD MILLION) 144
7.3.1.3 Poultry 144
7.3.1.3.1 The growth of this segment is driven by the growing poultry population and rising production volumes 144
TABLE 61 SOME OF THE IMPORTANT ZOONOTIC DISEASES AFFECTING POULTRY 145
TABLE 62 SOME IMPORTANT INFECTIOUS DISEASES AFFECTING POULTRY 145
TABLE 63 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR POULTRY,
BY COUNTRY, 2019–2026 (USD MILLION) 148
7.3.1.4 Other food-producing animals 148
TABLE 64 SOME OF THE MAJOR ZOONOTIC DISEASES AFFECTING OTHER FOOD -PRODUCING ANIMALS 149
TABLE 65 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR OTHER FOOD-PRODUCING ANIMALS, BY COUNTRY, 2019–2026 (USD MILLION) 150
7.3.2 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY INFECTION TYPE 150
TABLE 66 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION) 151
7.3.2.1 Bacterial infections 151
7.3.2.1.1 The bacterial infections segment accounted for the largest share of the food-producing animals market in 2020 151
TABLE 67 PRODUCTS OFFERED FOR THE DIAGNOSIS OF BACTERIAL INFECTIONS IN FOOD-PRODUCING ANIMALS 152
TABLE 68 BACTERIAL DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY REGION, 2019–2026 (USD MILLION) 153
7.3.2.2 Viral infections 153
7.3.2.2.1 Need for early disease diagnosis and the rising awareness for viral infections to support the market growth 153
TABLE 69 PRODUCTS OFFERED FOR THE DIAGNOSIS OF VIRAL INFECTIONS IN FOOD-PRODUCING ANIMALS 154
TABLE 70 VIRAL DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS,
BY REGION, 2019–2026 (USD MILLION) 155
7.3.2.3 Parasitic infections 156
7.3.2.3.1 Worm infestations are a significant problem for pet & companion animal owners 156
TABLE 71 PRODUCTS OFFERED FOR THE DIAGNOSIS OF PARASITIC INFECTIONS
IN FOOD-PRODUCING ANIMALS 156
TABLE 72 PARASITIC DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY REGION, 2019–2026 (USD MILLION) 157
7.3.2.4 Other infections 157
TABLE 73 PRODUCTS OFFERED FOR THE DIAGNOSIS OF FUNGAL INFECTIONS IN FOOD-PRODUCING ANIMALS 158
TABLE 74 PRODUCTS OFFERED FOR THE DIAGNOSIS OF OTHER INFECTIONS
IN FOOD- PRODUCING ANIMALS 158
TABLE 75 OTHER INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY REGION, 2019–2026 (USD MILLION) 159
8 VETERINARY INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY END USER 160
8.1 INTRODUCTION 161
TABLE 76 VETERINARY INFECTIOUS DISEASES DIAGNOSTICS MARKET, BY END USER, 2019–2026 (USD MILLION) 161
8.2 VETERINARY REFERENCE LABORATORIES 161
8.2.1 VETERINARY REFERENCE LABORATORIES IS THE LARGEST
END USER SEGMENT 161
TABLE 77 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR REFERENCE LABORATORIES, BY COUNTRY, 2019–2026 (USD MILLION) 162
8.3 VETERINARY HOSPITALS & CLINICS 163
8.3.1 INCREASED PET OWNERSHIP AND SPENDING ON PET CARE TO PROPEL MARKET GROWTH 163
FIGURE 33 US: PET INDUSTRY EXPENDITURE 163
FIGURE 34 ANNUAL ROUTINE VETERINARY VISIT EXPENDITURE: DOGS AND CATS 164
TABLE 78 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR VETERINARY HOSPITALS & CLINICS, BY COUNTRY, 2019–2026 (USD MILLION) 165
8.4 POINT-OF-CARE/ IN-HOUSE TESTING 165
8.4.1 POINT-OF-CARE TESTING IS EASY-TO-USE, COST-EFFECTIVE, AND OFFERS SWIFT RESULTS 165
TABLE 79 KEY PRODUCTS OFFERED BY MARKET PLAYERS 166
TABLE 80 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR POINT-OF-CARE/ IN-HOUSE TESTING, BY COUNTRY, 2019–2026 (USD MILLION) 167
8.5 VETERINARY RESEARCH INSTITUTES & UNIVERSITIES 167
8.5.1 INCREASING COLLABORATIONS BETWEEN PRIVATE COMPANIES AND VETERINARY RESEARCH INSTITUTES & UNIVERSITIES TO DRIVE MARKET GROWTH 167
TABLE 81 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR
VETERINARY RESEARCH INSTITUTES & UNIVERSITIES, BY COUNTRY,
2019–2026 (USD MILLION) 169
9 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY REGION 170
9.1 INTRODUCTION 171
TABLE 82 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY REGION, 2019–2026 (USD MILLION) 171
9.2 NORTH AMERICA 172
FIGURE 35 EXPECTED GROWTH IN THE NUMBER OF VETERINARIANS IN NORTH AMERICA 173
FIGURE 36 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SNAPSHOT 173
TABLE 83 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 174
TABLE 84 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION) 174
TABLE 85 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 174
TABLE 86 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 175
TABLE 87 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION) 175
TABLE 88 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 175
TABLE 89 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION) 176
TABLE 90 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 176
TABLE 91 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION) 176
TABLE 92 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2019–2026 (USD MILLION) 177
9.2.1 US 177
9.2.1.1 The US dominated the North American veterinary infectious disease diagnostics market in 2020 177
FIGURE 37 US: DOGS POPULATION, 2012–2020 (MILLION) 177
FIGURE 38 US: EXPENDITURE ON VET VISITS 178
TABLE 93 US: FOOD-PRODUCING ANIMAL POPULATION, 2001–2019 (MILLION) 178
FIGURE 39 US: NUMBER OF CATS AND DOGS TESTED POSITIVE FOR COVID-19 (2020) 179
TABLE 94 US: NUMBER OF VETERINARIANS IN PRIVATE CLINICAL PRACTICES,
2014–2019 179
TABLE 95 US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY TECHNOLOGY, 2019–2026 (USD MILLION) 180
TABLE 96 US: VETERINARY INFECTIOUS DISEASE IMMUNODIAGNOSTICS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 180
TABLE 97 US: VETERINARY INFECTIOUS DISEASE MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 180
TABLE 98 US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION) 181
TABLE 99 US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 181
TABLE 100 US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION) 181
TABLE 101 US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 182
TABLE 102 US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION) 182
TABLE 103 US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY END USER, 2019–2026 (USD MILLION) 182
9.2.2 CANADA 183
9.2.2.1 Growing pet adoption in Canada to drive the market growth 183
FIGURE 40 CANADA: COMPANION ANIMAL POPULATION, 2016–2020 (MILLION) 183
TABLE 104 CANADA: LARGE ANIMAL POPULATION, 2001–2019 (MILLION) 183
TABLE 105 CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY TECHNOLOGY, 2019–2026 (USD MILLION) 184
TABLE 106 CANADA: VETERINARY INFECTIOUS DISEASE IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 184
TABLE 107 CANADA: VETERINARY INFECTIOUS DISEASE MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 184
TABLE 108 CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY ANIMAL TYPE, 2019–2026 (USD MILLION) 185
TABLE 109 CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 185
TABLE 110 CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION) 185
TABLE 111 CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 186
TABLE 112 CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION) 186
TABLE 113 CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY END USER, 2019–2026 (USD MILLION) 186
9.3 EUROPE 187
TABLE 114 EUROPE: COMPANION POPULATION, 2019 (MILLION) 187
TABLE 115 EUROPE: LIVESTOCK POPULATION, 2019 (MILLION) 187
FIGURE 41 EU-27: LIVESTOCK POPULATION, 2012-2019 (MILLION) 188
TABLE 116 EUROPE: NUMBER OF VETERINARIANS, 2012–2019 189
TABLE 117 EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY COUNTRY, 2019–2026 (USD MILLION) 189
TABLE 118 EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY TECHNOLOGY, 2019–2026 (USD MILLION) 189
TABLE 119 EUROPE: VETERINARY INFECTIOUS DISEASE IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 190
TABLE 120 EUROPE: VETERINARY INFECTIOUS DISEASE MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 190
TABLE 121 EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTIC MARKET,
BY ANIMAL TYPE, 2019–2026 (USD MILLION) 190
TABLE 122 EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 191
TABLE 123 EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION) 191
TABLE 124 EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 191
TABLE 125 EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS
MARKET FOR FOOD-PRODUCING ANIMALS, BY INFECTION TYPE,
2019–2026 (USD MILLION) 192
TABLE 126 EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY END USER, 2019–2026 (USD MILLION) 192
9.3.1 GERMANY 192
9.3.1.1 Rising awareness regarding zoonotic diseases to drive the market growth in Germany 192
TABLE 127 GERMANY: COMPANION ANIMAL POPULATION, 2016–2019 (MILLION) 193
TABLE 128 GERMANY: LIVESTOCK ANIMAL POPULATION, 2016–2019 (MILLION) 193
TABLE 129 GERMANY: NUMBER OF VETERINARIANS, 2014 VS. 2019 194
TABLE 130 GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY TECHNOLOGY, 2019–2026 (USD MILLION) 194
TABLE 131 GERMANY: VETERINARY INFECTIOUS DISEASE IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 194
TABLE 132 GERMANY: VETERINARY INFECTIOUS DISEASE MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 195
TABLE 133 GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY ANIMAL TYPE, 2019–2026 (USD MILLION) 195
TABLE 134 GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 195
TABLE 135 GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION) 196
TABLE 136 GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 196
TABLE 137 GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS
MARKET FOR FOOD-PRODUCING ANIMALS, BY INFECTION TYPE,
2019–2026 (USD MILLION) 196
TABLE 138 GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTIC MARKET,
BY END USER, 2019–2026 (USD MILLION) 197
9.3.2 UK 197
9.3.2.1 The UK is the fastest-growing market for veterinary infectious disease diagnostics in Europe 197
TABLE 139 UK: COMPANION ANIMAL POPULATION (2010–2019) (MILLION) 197
TABLE 140 UK: LIVESTOCK ANIMAL POPULATION, 2016–2019 (MILLION) 198
TABLE 141 UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY TECHNOLOGY, 2019–2026 (USD MILLION) 198
TABLE 142 UK: VETERINARY INFECTIOUS DISEASE IMMUNODIAGNOSTICS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 199
TABLE 143 UK: VETERINARY INFECTIOUS DISEASE MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 199
TABLE 144 UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION) 199
TABLE 145 UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 200
TABLE 146 UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION) 200
TABLE 147 UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 200
TABLE 148 UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION) 201
TABLE 149 UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY END USER, 2019–2026 (USD MILLION) 201
9.3.3 FRANCE 201
9.3.3.1 France is one of the leading markets for companion pet ownership 201
TABLE 150 FRANCE: COMPANION ANIMAL POPULATION, 2010–2019 (MILLION) 202
TABLE 151 FRANCE: LIVESTOCK ANIMAL POPULATION, 2016–2019 (MILLION) 202
TABLE 152 FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY TECHNOLOGY, 2019–2026 (USD MILLION) 203
TABLE 153 FRANCE: VETERINARY INFECTIOUS DISEASE IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 203
TABLE 154 FRANCE: VETERINARY INFECTIOUS DISEASE MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 203
TABLE 155 FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTIC MARKET,
BY ANIMAL TYPE, 2019–2026 (USD MILLION) 204
TABLE 156 FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 204
TABLE 157 FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION) 204
TABLE 158 FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 205
TABLE 159 FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY INFECTION TYPE,
2019–2026 (USD MILLION) 205
TABLE 160 FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTIC MARKET,
BY END USER, 2019–2026 (USD MILLION) 205
9.3.4 ITALY 206
9.3.4.1 Rising awareness about pet healthcare to propel the market growth for veterinary diagnostic products in Italy 206
TABLE 161 ITALY: COMPANION ANIMAL POPULATION, 2012–2019 (MILLION) 206
TABLE 162 ITALY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY TECHNOLOGY, 2019–2026 (USD MILLION) 207
TABLE 163 ITALY: VETERINARY INFECTIOUS IMMUNODIAGNOSTICS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 207
TABLE 164 ITALY: VETERINARY INFECTIOUS DISEASE MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 207
TABLE 165 ITALY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION) 208
TABLE 166 ITALY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 208
TABLE 167 ITALY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION) 208
TABLE 168 ITALY: VETERINARY DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 209
TABLE 169 ITALY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION) 209
TABLE 170 ITALY: VETERINARY DIAGNOSTICS MARKET, BY END USER,
2019–2026 (USD MILLION) 209
9.3.5 SPAIN 210
9.3.5.1 Growing demand for pig & poultry products to support the adoption of veterinary diagnostic products in Spain 210
TABLE 171 SPAIN: COMPANION ANIMAL POPULATION, 2016–2019 (MILLION) 210
TABLE 172 SPAIN: LIVESTOCK ANIMAL POPULATION, 2016–2019 (MILLION) 211
TABLE 173 SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY TECHNOLOGY, 2019–2026 (USD MILLION) 211
TABLE 174 SPAIN: VETERINARY INFECTIOUS IMMUNODIAGNOSTICS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 211
TABLE 175 SPAIN: VETERINARY INFECTIOUS MOLECULAR DIAGNOSTICS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 212
TABLE 176 SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY ANIMAL TYPE, 2019–2026 (USD MILLION) 212
TABLE 177 SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 212
TABLE 178 SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION) 213
TABLE 179 SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 213
TABLE 180 SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION) 213
TABLE 181 SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY END USER, 2019–2026 (USD MILLION) 214
9.3.6 REST OF EUROPE 214
TABLE 182 ROE: COMPANION ANIMAL OWNERSHIP, BY COUNTRY, 2019 (MILLION) 214
TABLE 183 ROE: LIVESTOCK ANIMAL POPULATION, BY COUNTRY, 2019 (MILLION) 215
TABLE 184 ROE: NUMBER OF VETERINARIANS AND PARAVETERINARIANS,
2010 VS. 2019 215
TABLE 185 ROE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY TECHNOLOGY, 2019–2026 (USD MILLION) 215
TABLE 186 ROE: VETERINARY INFECTIOUS IMMUNODIAGNOSTICS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 216
TABLE 187 ROE: VETERINARY INFECTIOUS MOLECULAR DIAGNOSTICS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 216
TABLE 188 ROE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION) 216
TABLE 189 ROE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 217
TABLE 190 ROE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION) 217
TABLE 191 ROE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 217
TABLE 192 ROE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION) 218
TABLE 193 ROE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2019–2026 (USD MILLION) 218

Lateral Flow Assay Components Market by Type, Application Type (Clinical Testing (Infectious, Cardiac Marker Test) Veterinary, Food Safety), Technique...

Publisher:        MarketsandMarkets

# of Pages:        224

Rating: 

1 User License $4,950

Publication Date:  April, 2022

Price:       $4,950 / User License




1 INTRODUCTION 33
1.1 OBJECTIVES OF THE STUDY 33
1.2 MARKET DEFINITION 33
1.2.1 CATEGORY-WISE INCLUSIONS AND EXCLUSIONS
IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 33
1.3 MARKET SCOPE 34
1.3.1 MARKETS COVERED 34
FIGURE 1 LATERAL FLOW ASSAY COMPONENTS MARKET SEGMENTATION 34
1.3.2 YEARS CONSIDERED FOR THE STUDY 35
1.4 CURRENCY 35
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 35
1.5 STAKEHOLDERS 35
2 RESEARCH METHODOLOGY 36
2.1 RESEARCH APPROACH 36
FIGURE 2 RESEARCH DESIGN 36
2.1.1 SECONDARY DATA 36
2.1.1.1 Key data from secondary sources 37
2.1.2 PRIMARY DATA 38
2.1.2.1 Primary sources 38
2.1.2.2 Key data from primary sources 39
2.1.2.3 Breakdown of primaries 39
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE):
BY COMPANY TYPE, DESIGNATION, AND REGION 39
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION 40
2.2 MARKET SIZE ESTIMATION 40
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2021) 41
FIGURE 6 SUPPLY-SIDE ANALYSIS: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 42
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 44
FIGURE 7 DATA TRIANGULATION METHODOLOGY 45
2.4 KEY INDUSTRY INSIGHTS 46
2.5 LIMITATIONS 46
2.5.1 METHODOLOGY-RELATED LIMITATIONS 46
2.6 RISK ASSESSMENT 47
2.7 ASSUMPTIONS FOR THE STUDY 47
 
3 EXECUTIVE SUMMARY 48
FIGURE 8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2022 VS. 2027 (USD MILLION) 48
FIGURE 9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2022 VS. 2027 (USD MILLION) 49
FIGURE 10 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2022 VS. 2027 (USD MILLION) 50
FIGURE 11 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2022 VS. 2027 (USD MILLION) 51
FIGURE 12 GEOGRAPHICAL SNAPSHOT OF THE LATERAL FLOW ASSAY COMPONENTS MARKET 52
4 PREMIUM INSIGHTS 53
4.1 LATERAL FLOW ASSAY COMPONENTS MARKET OVERVIEW 53
FIGURE 13 RISING NUMBER OF LOCAL MANUFACTURERS FOR COMPONENTS IS DRIVING THE GROWTH OF THE LATERAL FLOW ASSAY COMPONENTS MARKET 53
4.2 REGIONAL MIX: LATERAL FLOW ASSAY COMPONENTS MARKET 54
FIGURE 14 APAC TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 54
4.3 ASIA PACIFIC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE AND COUNTRY 55
FIGURE 15 MEMBRANES ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC MARKET IN 2021 55
4.4 LATERAL FLOW ASSAY COMPONENTS MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES 56
4.5 LATERAL FLOW ASSAY COMPONENTS MARKET: DEVELOPED VS. DEVELOPING COUNTRIES 56
5 MARKET OVERVIEW 57
5.1 INTRODUCTION 57
5.2 MARKET DYNAMICS: IMPACT ANALYSIS 57
5.2.1 DRIVERS 58
5.2.1.1 Growing demand for lateral flow assay kits due
to the COVID-19 pandemic 58
5.2.1.2 Growing usage of home-based lateral flow assay devices 58
5.2.1.3 Growing demand for point-of-care testing 58
5.2.1.4 Increasing public-private investments to develop lateral flow assays 59
5.2.2 RESTRAINTS 59
5.2.2.1 Availability of alternative diagnostic technologies 59
5.2.3 OPPORTUNITIES 59
5.2.3.1 Evolving applications of lateral flow assays 59
5.2.4 CHALLENGES 60
5.2.4.1 Requirement of specialized storage and shipping facilities for membranes 60
5.3 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 60
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES (YC-YCC) IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 60
FIGURE 16 YC–YCC SHIFT IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 61
5.5 AVERAGE SELLING PRICE TREND 61
TABLE 2 AVERAGE SELLING PRICE OF LATERAL FLOW ASSAY COMPONENTS,
BY REGION, 2021 (USD) 61
5.6 ECOSYSTEM MARKET MAP 62
FIGURE 17 ECOSYSTEM: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 62
5.7 PATENT ANALYSIS 63
5.7.1 PATENT PUBLICATION TRENDS FOR LATERAL FLOW ASSAYS 63
FIGURE 18 GLOBAL PATENT PUBLICATION TRENDS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET, 2016–2021 64
5.7.2 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 64
FIGURE 19 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR LATERAL FLOW ASSAYS COMPONENTS, 2016–2021 64
5.8 VALUE CHAIN ANALYSIS 65
5.9 REGULATORY LANDSCAPE 66
TABLE 3 REGULATORY STANDARDS/APPROVALS REQUIRED FOR LATERAL FLOW IMMUNOASSAY PRODUCTS, BY COUNTRY/REGION 66
5.9.1 NORTH AMERICA 66
5.9.2 EUROPE 67
5.9.3 ASIA PACIFIC 67
5.9.3.1 India 67
5.9.3.2 China 67
5.9.3.3 Japan 68
5.10 TECHNOLOGY ANALYSIS 69
5.10.1 KEY TECHNOLOGY: LATERAL FLOW ASSAYS 69
5.11 KEY CONFERENCES & EVENTS DURING 2021–2023 69
TABLE 4 LATERAL FLOW ASSAY COMPONENTS MARKET: DETAILED LIST OF CONFERENCES & EVENTS 69
5.12 KEY STAKEHOLDERS & BUYING CRITERIA 70
5.12.1 KEY STAKEHOLDERS IN THE BUYING PROCESS 70
FIGURE 20 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP 3 APPLICATIONS 70
TABLE 5 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP 3 APPLICATIONS 70
5.12.2 BUYING CRITERIA 71
FIGURE 21 KEY BUYING CRITERIA FOR THE TOP 3 APPLICATIONS 71
TABLE 6 KEY BUYING CRITERIA FOR THE TOP 3 APPLICATIONS 71
5.13 PORTER’S FIVE FORCES ANALYSIS 72
TABLE 7 LATERAL FLOW ASSAY COMPONENTS MARKET:
PORTER’S FIVE FORCES ANALYSIS 72
5.13.1 THREAT FROM NEW ENTRANTS 72
5.13.2 THREAT FROM SUBSTITUTES 72
5.13.3 BARGAINING POWER OF BUYERS 73
5.13.4 BARGAINING POWER OF SUPPLIERS 73
5.13.5 INTENSITY OF COMPETITIVE RIVALRY 73
6 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE 74
6.1 INTRODUCTION 75
TABLE 8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 75
6.2 MEMBRANES 75
TABLE 9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE,
2020–2027 (USD MILLION) 76
TABLE 10 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEMBRANES,
BY COUNTRY, 2020–2027 (USD MILLION) 76
6.2.1 NITROCELLULOSE MEMBRANES 77
6.2.1.1 Advantages of nitrocellulose membranes such as high protein-binding affinity and compatibility with a wide range of detection methods to drive market growth 77
TABLE 11 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES, BY COUNTRY, 2020–2027 (USD MILLION) 77
TABLE 12 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES (1 X 1 M SHEETS), BY REGION, 2020–2027 (IN THOUSANDS) 78
TABLE 13 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES (20 MM X 1 M ROLLS), BY REGION, 2020–2027 (IN MILLIONS) 78
6.2.2 OTHER MEMBRANES 78
TABLE 14 LATERAL FLOW ASSAY COMPONENTS MARKET FOR OTHER MEMBRANES,
BY COUNTRY, 2020–2027 (USD MILLION) 79
6.3 PADS 80
TABLE 15 EXAMPLES OF DIFFERENT MATERIALS USED IN MANUFACTURING LATERAL FLOW ASSAY PADS 80
TABLE 16 LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 80
TABLE 17 LATERAL FLOW ASSAY COMPONENTS MARKET FOR PADS, BY COUNTRY, 2020–2027 (USD MILLION) 81
6.3.1 SAMPLE PADS 81
6.3.1.1 Ability to promote even and controlled distribution of samples to drive market growth 81
TABLE 18 LATERAL FLOW ASSAY COMPONENTS MARKET FOR SAMPLE PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 82
6.3.2 CONJUGATE PADS 82
6.3.2.1 Conjugate pads play an important role in controlling the performance of lateral flow immunoassays 82
TABLE 19 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CONJUGATE PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 83
6.3.3 ABSORBENT PADS 84
6.3.3.1 Absorbent pads prevent backflow—a key factor driving market growth 84
TABLE 20 LATERAL FLOW ASSAY COMPONENTS MARKET FOR ABSORBENT PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 84
6.4 OTHER COMPONENTS 84
TABLE 21 OTHER LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 85
7 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION 86
7.1 INTRODUCTION 87
TABLE 22 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 87
7.2 CLINICAL TESTING 87
TABLE 23 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 88
TABLE 24 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS,
BY COUNTRY, 2020–2027 (USD MILLION) 88
7.2.1 INFECTIOUS DISEASE TESTING 89
7.2.1.1 Rising demand for infectious disease testing in emerging markets to drive market growth 89
TABLE 25 LATERAL FLOW ASSAY COMPONENTS MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 89
7.2.2 PREGNANCY & FERTILITY TESTING 90
7.2.2.1 Growing infertility levels due to changing lifestyles—a key factor driving market growth 90
TABLE 26 LATERAL FLOW ASSAY COMPONENTS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 90
7.2.3 CARDIAC MARKER TESTING 91
7.2.3.1 Rising prevalence of cardiovascular diseases and growing government support to drive growth in this market segment 91
TABLE 27 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CARDIAC MARKER TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 92
7.2.4 CHOLESTEROL TESTING/LIPID PROFILING 92
7.2.4.1 Growing prevalence of obesity and CVD—
a key factor driving market growth 92
TABLE 28 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CHOLESTEROL TESTING/LIPID PROFILING, BY COUNTRY, 2020–2027 (USD MILLION) 93
7.2.5 DRUGS-OF-ABUSE TESTING 93
7.2.5.1 Technological advancements and a growing focus on workplace
drug testing are driving market growth 93
TABLE 29 LATERAL FLOW ASSAY COMPONENTS MARKET FOR DRUGS-OF-ABUSE TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 94
7.2.6 OTHER CLINICAL TESTING APPLICATIONS 94
TABLE 30 LATERAL FLOW ASSAY COMPONENTS MARKET FOR OTHER CLINICAL TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 95
7.3 VETERINARY DIAGNOSTICS 95
7.3.1 INFECTIOUS DISEASE OUTBREAKS (PARTICULARLY IN LARGE LIVESTOCK ANIMALS) TO DRIVE MARKET GROWTH 95
TABLE 31 LATERAL FLOW ASSAY COMPONENTS MARKET FOR VETERINARY DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 96
7.4 FOOD SAFETY & ENVIRONMENTAL TESTING 96
7.4.1 HIGH SENSITIVITY AND EASE OF USE ARE KEY FACTORS DRIVING THE DEMAND FOR LATERAL FLOW ASSAYS FOR FOOD SAFETY TESTING 96
TABLE 32 LATERAL FLOW ASSAY COMPONENTS MARKET FOR FOOD SAFETY & ENVIRONMENTAL TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 97
7.5 DRUG DEVELOPMENT & QUALITY TESTING 97
7.5.1 INCREASING FOCUS ON PRODUCT SAFETY AND QUALITY ASSURANCE TO DRIVE MARKET GROWTH IN THE COMING YEARS 97
TABLE 33 LATERAL FLOW ASSAY COMPONENTS MARKET FOR DRUG DEVELOPMENT & QUALITY TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 98
8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE 99
8.1 INTRODUCTION 100
TABLE 34 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 100
8.2 SANDWICH ASSAYS 100
8.2.1 SANDWICH ASSAYS PROVIDE HIGHER LEVELS OF ASSAY SENSITIVITY AND SPECIFICITY THAN OTHER ASSAY TECHNIQUES—A KEY FACTOR DRIVING GROWTH IN THIS MARKET SEGMENT 100
TABLE 35 LATERAL FLOW ASSAY COMPONENTS MARKET FOR SANDWICH ASSAYS,
BY COUNTRY, 2020–2027 (USD MILLION) 101
8.3 COMPETITIVE ASSAYS 101
8.3.1 REDUCED SELECTIVITY AND SENSITIVITY OF COMPETITIVE ASSAYS IN RELATION TO SANDWICH ASSAYS COULD HAMPER MARKET GROWTH 101
TABLE 36 LATERAL FLOW ASSAY COMPONENTS MARKET FOR COMPETITIVE ASSAYS,
BY COUNTRY, 2020–2027 (USD MILLION) 102
8.4 MULTIPLEX DETECTION ASSAYS 102
8.4.1 INCREASING ADOPTION OF MULTI-ANALYTE ASSAYS AMONG CLINICIANS TO DRIVE MARKET GROWTH 102
TABLE 37 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MULTIPLEX DETECTION ASSAYS, BY COUNTRY, 2020–2027 (USD MILLION) 103
9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER 104
9.1 INTRODUCTION 105
TABLE 38 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 105
9.2 MEDICAL DEVICE MANUFACTURING COMPANIES 105
9.2.1 INCREASING USE OF POC TESTS IS DRIVING THE ADOPTION OF LATERAL FLOW ASSAY COMPONENTS AMONG MEDICAL DEVICE MANUFACTURING COMPANIES 105
TABLE 39 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEDICAL DEVICE MANUFACTURING COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION) 106
9.3 MEDICAL DEVICE CONTRACT MANUFACTURING COMPANIES 106
9.3.1 GROWING INCLINATION TOWARD FAST AND EARLY DIAGNOSIS, ESPECIALLY IN RELATION TO THE CURRENT COVID-19 SCENARIO, WILL DRIVE MARKET GROWTH 106
TABLE 40 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEDICAL DEVICE CONTRACT MANUFACTURING COMPANIES, BY COUNTRY,
2020–2027 (USD MILLION) 107
 
10 LATERAL FLOW ASSAY COMPONENTS MARKET, BY REGION 108
10.1 INTRODUCTION 109
FIGURE 22 CHINA TO REGISTER THE HIGHEST GROWTH IN THE LATERAL FLOW ASSAY COMPONENTS MARKET DURING THE FORECAST PERIOD 109
TABLE 41 LATERAL FLOW ASSAY COMPONENTS MARKET, BY REGION,
2020–2027 (USD MILLION) 110
10.2 NORTH AMERICA 110
TABLE 42 NORTH AMERICA: MACROECONOMIC INDICATORS 110
FIGURE 23 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET SNAPSHOT 111
TABLE 43 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY COUNTRY, 2020–2027 (USD MILLION) 112
TABLE 44 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 112
TABLE 45 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 112
TABLE 46 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY PAD TYPE, 2020–2027 (USD MILLION) 113
TABLE 47 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 113
TABLE 48 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 114
TABLE 49 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 114
TABLE 50 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 115
10.2.1 US 115
10.2.1.1 Increasing R&D investments and venture capital funding from both large and small firms towards the development of lateral flow assay diagnostics to drive market growth in the US 115
TABLE 51 US: MACROECONOMIC INDICATORS 116
TABLE 52 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 116
TABLE 53 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 116
TABLE 54 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 117
TABLE 55 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 117
TABLE 56 US: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 118
TABLE 57 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 118
TABLE 58 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 119
10.2.2 CANADA 119
10.2.2.1 Lateral flow assay components market in Canada is estimated to grow at a relatively lower rate than the US 119
TABLE 59 CANADA: MACROECONOMIC INDICATORS 119
TABLE 60 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 120
TABLE 61 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 120
TABLE 62 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 120
TABLE 63 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 121
TABLE 64 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 121
TABLE 65 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 122
TABLE 66 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 122
10.3 EUROPE 122
TABLE 67 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 123
TABLE 68 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 123
TABLE 69 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 123
TABLE 70 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 124
TABLE 71 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 124
TABLE 72 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 125
TABLE 73 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 125
TABLE 74 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 126
10.3.1 GERMANY 126
10.3.1.1 Growing demand for POC testing to drive the lateral flow assay components market in Germany 126
TABLE 75 GERMANY: MACROECONOMIC INDICATORS 126
TABLE 76 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 127
TABLE 77 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 127
TABLE 78 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 127
TABLE 79 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 128
TABLE 80 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 128
TABLE 81 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 129
TABLE 82 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 129
10.3.2 FRANCE 129
10.3.2.1 High prevalence of age-related chronic diseases and infectious diseases to drive market growth in France 129
TABLE 83 FRANCE: MACROECONOMIC INDICATORS 130
TABLE 84 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 130
TABLE 85 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 130
TABLE 86 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 131
TABLE 87 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 131
TABLE 88 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 132
TABLE 89 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 132
TABLE 90 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 133
10.3.3 UK 133
10.3.3.1 Severe impact of the second wave of COVID-19 in the first half of 2021 resulted in higher adoption of rapid COVID tests in the UK 133
TABLE 91 UK: MACROECONOMIC INDICATORS 134
TABLE 92 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 134
TABLE 93 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 134
TABLE 94 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 135
TABLE 95 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 135
TABLE 96 UK: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 136
TABLE 97 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 136
TABLE 98 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 137
10.3.4 ITALY 137
10.3.4.1 Growing initiatives towards decentralization of medical services in Italy are contributing to the market growth in the country 137
TABLE 99 ITALY: MACROECONOMIC INDICATORS 137
TABLE 100 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 138
TABLE 101 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 138
TABLE 102 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 138
TABLE 103 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 139
TABLE 104 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 139
TABLE 105 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 140
TABLE 106 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 140
10.3.5 SPAIN 140
10.3.5.1 Increasing focus of international organizations and domestic players on the development of POC products in the country to drive market growth 140
TABLE 107 SPAIN: MACROECONOMIC INDICATORS 141
TABLE 108 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 141
TABLE 109 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 142
TABLE 110 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 142
TABLE 111 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 142
TABLE 112 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 143
TABLE 113 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 143
TABLE 114 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 144
10.3.6 REST OF EUROPE 144
TABLE 115 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 144
TABLE 116 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 145
TABLE 117 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 145
TABLE 118 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 145
TABLE 119 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 146
TABLE 120 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 146
TABLE 121 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 147
10.4 ASIA PACIFIC 147
FIGURE 24 ASIA PACIFIC: LATERAL FLOW ASSAY COMPONENTS MARKET SNAPSHOT 148
TABLE 122 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 149
TABLE 123 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 149
TABLE 124 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 149
TABLE 125 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 150
TABLE 126 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 150
TABLE 127 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 151
TABLE 128 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 151
TABLE 129 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 152
10.4.1 CHINA 152
10.4.1.1 Higher exports of lateral flow assay components during the COVID-19 pandemic to drive market growth in the country 152
TABLE 130 CHINA: MACROECONOMIC INDICATORS 153
TABLE 131 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 153
TABLE 132 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 153
TABLE 133 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 154
TABLE 134 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 154
TABLE 135 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 155
TABLE 136 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 155
TABLE 137 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 156
10.4.2 JAPAN 156
10.4.2.1 Increasing prevalence of age-related illnesses driving the growth of the lateral flow assay components market in Japan 156
TABLE 138 JAPAN: MACROECONOMIC INDICATORS 157
TABLE 139 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 157
TABLE 140 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 157
TABLE 141 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 158
TABLE 142 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 158
TABLE 143 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 159
TABLE 144 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 159
TABLE 145 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 160
10.4.3 INDIA 160
10.4.3.1 Increasing number of local manufacturers, growing healthcare concerns, and rising income levels to propel the growth of this market 160
TABLE 146 INDIA: MACROECONOMIC INDICATORS 160
TABLE 147 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 161
TABLE 148 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 161
TABLE 149 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 161
TABLE 150 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 162
TABLE 151 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 162
TABLE 152 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 163
TABLE 153 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 163
10.4.4 AUSTRALIA 164
10.4.4.1 Increasing prevalence of infectious diseases, especially influenza, to drive the growth of the lateral flow assay components market in Australia 164
TABLE 154 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 164
TABLE 155 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 164
TABLE 156 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 165
TABLE 157 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 165
TABLE 158 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 166
TABLE 159 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 166
TABLE 160 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 167
10.4.5 REST OF ASIA PACIFIC 167
TABLE 161 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 167
TABLE 162 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 168
TABLE 163 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 168
TABLE 164 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 168
TABLE 165 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 169
TABLE 166 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 169
TABLE 167 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 170
 
10.5 LATIN AMERICA 170
10.5.1 HIGH DEMAND FOR HIV POC DEVICES IN THE REGION TO SUPPORT THE GROWTH OF THE MARKET 170
TABLE 168 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 171
TABLE 169 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 171
TABLE 170 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD
TYPE, 2020–2027 (USD MILLION) 171
TABLE 171 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 172
TABLE 172 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 172
TABLE 173 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 173
TABLE 174 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 173
10.6 MIDDLE EAST & AFRICA 173
10.6.1 SIGNIFICANT SUPPORT FROM GOVERNMENTS AND GLOBAL FIRMS TOWARDS EXPANDING HEALTHCARE SERVICES DRIVES THE ADOPTION OF LATERAL FLOW ASSAYS 173
TABLE 175 MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS 174
TABLE 176 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TYPE, 2020–2027 (USD MILLION) 174
TABLE 177 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 175
TABLE 178 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY PAD TYPE, 2020–2027 (USD MILLION) 175
TABLE 179 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 175
TABLE 180 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 176
TABLE 181 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 176
TABLE 182 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 177
11 COMPETITIVE LANDSCAPE 178
11.1 OVERVIEW 178
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 178
FIGURE 25 OVERVIEW OF STRATEGIES ADOPTED BY MAJOR PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 179
11.3 REVENUE SHARE ANALYSIS FOR KEY PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 179
FIGURE 26 REVENUE SHARE ANALYSIS FOR THE KEY PLAYERS
IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 180
11.4 MARKET SHARE ANALYSIS 180
FIGURE 27 LATERAL FLOW ASSAY COMPONENTS MARKET SHARE ANALYSIS, BY KEY PLAYER (2021) 181
TABLE 183 LATERAL FLOW ASSAY COMPONENTS MARKET: DEGREE OF COMPETITION 182
11.5 R&D ASSESSMENT OF KEY PLAYERS 183
FIGURE 28 R&D EXPENDITURE: MAJOR PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET, 2018 VS. 2020 183
11.6 GEOGRAPHIC REVENUE ASSESSMENT OF KEY PLAYERS 183
FIGURE 29 GEOGRAPHIC REVENUE ASSESSMENT: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 184
11.7 COMPANY EVALUATION QUADRANT 184
11.7.1 STARS 184
11.7.2 PERVASIVE PLAYERS 184
11.7.3 EMERGING LEADERS 185
11.7.4 PARTICIPANTS 185
FIGURE 30 LATERAL FLOW ASSAY COMPONENTS MARKET: COMPANY EVALUATION MATRIX, 2021 185
11.8 COMPETITIVE BENCHMARKING 186
11.8.1 OVERALL COMPANY FOOTPRINT 186
TABLE 184 OVERALL COMPANY FOOTPRINT (17 COMPANIES) 186
TABLE 185 COMPANY FOOTPRINT: BY TYPE (17 COMPANIES) 187
TABLE 186 COMPANY FOOTPRINT: BY REGION (17 COMPANIES) 188
11.9 COMPETITIVE SCENARIO 188
11.9.1 DEALS 189
TABLE 187 DEALS, JANUARY 2019–FEBRUARY 2022 189
11.9.2 OTHER DEVELOPMENTS 189
TABLE 188 OTHER DEVELOPMENTS, JANUARY 2019–FEBRUARY 2022 189
12 COMPANY PROFILES 190
12.1 KEY PLAYERS 190
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 DANAHER CORPORATION (PALL CORPORATION AND CYTIVA LIFE SCIENCE) 190
TABLE 189 DANAHER CORPORATION: BUSINESS OVERVIEW 190
FIGURE 31 DANAHER CORPORATION: COMPANY SNAPSHOT (2020) 191
12.1.2 SARTORIUS STEDIM BIOTECH 195
TABLE 190 SARTORIUS STEDIM BIOTECH: BUSINESS OVERVIEW 195
12.1.3 MERCK KGAA 199
TABLE 191 MERCK KGAA: BUSINESS OVERVIEW 199
FIGURE 33 MERCK KGAA: COMPANY SNAPSHOT (2020) 200
12.1.4 AHLSTROM-MUNKSJÖ 204
TABLE 192 AHLSTROM-MUNKSJÖ: BUSINESS OVERVIEW 204
FIGURE 34 AHLSTROM-MUNKSJÖ: COMPANY SNAPSHOT (2020) 205
12.1.5 ADVANCED MICRODEVICES PVT. LTD. 208
TABLE 193 ADVANCED MICRODEVICES PVT. LTD.: BUSINESS OVERVIEW 208
12.1.6 DCN DIAGNOSTICS 210
TABLE 194 DCN DIAGNOSTICS: BUSINESS OVERVIEW 210
12.2 OTHER PLAYERS 211
12.2.1 FORTIS LIFE SCIENCES 211
TABLE 195 FORTIS LIFE SCIENCES: BUSINESS OVERVIEW 211
12.2.2 HANGZHOU COBETTER FILTRATION EQUIPMENT CO. LTD 212
TABLE 196 HANGZHOU COBETTER FILTRATION EQUIPMENT CO. LTD.:
BUSINESS OVERVIEW 212
12.2.3 AXIVA SICHEM BIOTECH 214
TABLE 197 AXIVA SICHEM BIOTECH: BUSINESS OVERVIEW 214
12.2.4 NUPORE FILTRATION SYSTEM 216
TABLE 198 NUPORE FILTRATION SYSTEM: BUSINESS OVERVIEW 216
12.2.5 BALLYA BIO 217
TABLE 199 BALLYA BIO: BUSINESS OVERVIEW 217
12.2.6 RUNBIO BIOTECH CO. LTD. 219
TABLE 200 RUNBIO BIOTECH CO. LTD.: BUSINESS OVERVIEW 219
12.2.7 NEENAH GESSNER 220
TABLE 201 NEENAH GESSNER: BUSINESS OVERVIEW 220
12.2.8 MAXIM BIOMEDICAL 221
TABLE 202 MAXIM BIOMEDICAL: BUSINESS OVERVIEW 221
12.2.9 CYTODIAGNOSTICS 222
TABLE 203 CYTODIAGNOSTICS: BUSINESS OVERVIEW 222
12.2.10 SENOVA GMBH 223
TABLE 204 SENOVA GMBH: BUSINESS OVERVIEW 223
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX 224
13.1 DISCUSSION GUIDE 224
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 229
13.3 AVAILABLE CUSTOMIZATIONS 231
13.4 RELATED REPORTS 231
13.5 AUTHOR DETAILS 232

US Healthcare Environmental Services Market by Type (Janitorial/Core-Cleaning, Infection Control & Prevention, Front-of-house cleaning & Brand Experie...

Publisher:        MarketsandMarkets

# of Pages:        126

Rating: 

1 User License $4,950

Publication Date:  March, 2022

Price:       $4,950 / User License




1 INTRODUCTION 15
1.1 OBJECTIVES OF THE STUDY 15
1.2 MARKET DEFINITION & SCOPE 15
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 16
1.2.2 MARKET SEGMENTATION 16
FIGURE 1 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET SEGMENTATION 16
1.2.3 YEARS CONSIDERED FOR THE STUDY 17
1.3 CURRENCY 17
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 17
1.4 STAKEHOLDERS 18
2 RESEARCH METHODOLOGY 19
2.1 RESEARCH APPROACH 19
FIGURE 2 RESEARCH DESIGN 19
2.1.1 SECONDARY RESEARCH 20
2.1.1.1 Key data from secondary sources 21
2.1.2 PRIMARY RESEARCH 21
FIGURE 3 PRIMARY SOURCES 22
2.1.2.1 Key data from primary sources 23
2.1.2.2 Insights from primary experts 23
2.1.2.3 Breakdown of primary interviews 24
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE (SUPPLY & DEMAND SIDE) AND DESIGNATION 24
2.2 MARKET SIZE ESTIMATION 25
FIGURE 5 MARKET SIZE APPROACH – REVENUE SHARE ANALYSIS 25
FIGURE 6 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 26
FIGURE 7 DEMAND-SIDE APPROACH 28
2.3 DATA TRIANGULATION 29
FIGURE 8 DATA TRIANGULATION METHODOLOGY 29
2.4 MARKET RANKING ANALYSIS 30
2.5 ASSUMPTIONS FOR THE STUDY 30
2.6 LIMITATIONS 31
2.6.1 METHODOLOGY-RELATED LIMITATIONS 31
2.6.2 SCOPE-RELATED LIMITATIONS 31
2.7 RISK ASSESSMENT 31
TABLE 2 RISK ASSESSMENT: US HEALTHCARE ENVIRONMENTAL SERVICES MARKET 31
 
3 EXECUTIVE SUMMARY 32
FIGURE 9 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION) 32
FIGURE 10 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET,
BY FACILITY TYPE, 2021 VS. 2026 (USD MILLION) 33
4 PREMIUM INSIGHTS 34
4.1 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET OVERVIEW 34
FIGURE 11 STRINGENT REGULATORY GUIDELINES ON INFECTION CONTROL & PREVENTION METHODS IS A KEY FACTOR DRIVING THE MARKET GROWTH 34
4.2 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE AND FACILITY TYPE 35
FIGURE 12 JANITORIAL/CORE-CLEANING SERVICES ACCOUNTED FOR THE LARGEST SHARE OF THE US HEALTHCARE ENVIRONMENTAL SERVICES
MARKET IN 2020 35
4.3 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE (2021–2026) 36
FIGURE 13 ACUTE CARE FACILITIES TO DOMINATE THE US HEALTHCARE ENVIRONMENTAL SERVICES MARKET DURING THE FORECAST PERIOD 36
5 MARKET OVERVIEW 37
5.1 INTRODUCTION 37
5.2 MARKET DYNAMICS 37
TABLE 3 MARKET DYNAMICS: HEALTHCARE ENVIRONMENTAL SERVICES MARKET 37
5.2.1 MARKET DRIVERS 38
5.2.1.1 Increasing prevalence of Hospital-acquired infections (HAIs) 38
5.2.1.2 Rising number of hospital admissions and surgeries 39
TABLE 4 US: PERCENTAGE INCREASE IN THE NUMBER OF SURGERIES PERFORMED 39
FIGURE 14 TOTAL ADMISSIONS IN ALL US HOSPITALS 40
FIGURE 15 TOTAL NUMBER OF HOSPITALS IN THE US 40
5.2.1.3 Shortage of in-house expertise and the rising need to reduce healthcare costs 41
5.2.1.4 Increasing outsourcing of cleaning services 41
5.2.2 MARKET RESTRAINTS 41
5.2.2.1 Healthcare facilities with an in-house EVS department 41
5.2.3 MARKET OPPORTUNITIES 42
5.2.3.1 Sustained acquisitions among strategic & financial buyers 42
TABLE 5 COMPANY ACQUISITIONS 42
5.2.4 MARKET CHALLENGES 42
5.2.4.1 Noncompliance with cleaning standards by EVS providers 42
5.3 INDUSTRY TRENDS 43
5.3.1 EMERGENCE OF NEW SURFACE DISINFECTANTS &
GREEN CLEANING PRODUCTS 43
5.3.2 DISINFECTION ROBOTS 44
5.3.3 MONITORING TOOLS FOR CLEANING QUALITY ASSESSMENT 44
5.4 TECHNOLOGY ANALYSIS 45
TABLE 6 TECHNOLOGY INNOVATION IN THE HEALTHCARE ENVIRONMENTAL
SERVICES MARKET 45
5.5 PATENT ANALYSIS 45
5.5.1 PATENT PUBLICATION TRENDS FOR HEALTHCARE ENVIRONMENTAL SERVICES 46
FIGURE 16 PATENT PUBLICATION TRENDS (JANUARY 2011–DECEMBER 2021) 46
5.5.2 JURISDICTION AND TOP APPLICANT ANALYSIS 47
FIGURE 17 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR HEALTHCARE ENVIRONMENTAL SERVICES PATENTS (JANUARY 2011–JANUARY 2022) 47
FIGURE 18 TOP APPLICANT COUNTRIES/REGIONS FOR HEALTHCARE ENVIRONMENTAL SERVICES PATENTS (JANUARY 2011–JANUARY 2022) 48
TABLE 7 LIST OF PATENTS/PATENT APPLICATIONS IN THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET, 2020–2021 48
5.6 IMPACT OF COVID-19 ON THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET 50
6 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE 51
6.1 INTRODUCTION 52
TABLE 8 US: HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 52
6.2 JANITORIAL SERVICES/CORE-CLEANING SERVICES 52
6.2.1 MANDATORY REGULAR CLEANING AND DISINFECTION OF HEALTHCARE FACILITIES TO DRIVE THE MARKET GROWTH 52
6.3 INFECTION PREVENTION & CONTROL SERVICES 53
TABLE 9 US: INFECTION PREVENTION & CONTROL SERVICE MARKET, BY TYPE,
2019–2026 (USD MILLION) 53
6.3.1 SPECIALIZED CLEANING SERVICES 53
6.3.1.1 Rising adoption of specialized services to reduce HAIs to drive the market growth 53
6.3.2 INFECTION PREVENTION & CONTROL CONSULTATION SERVICES 53
6.3.2.1 The provision of customized environmental services specific
to a healthcare facility ensures market demand 53
6.4 ENHANCED CLEANING TECHNOLOGY 54
6.4.1 RISING DEMAND FOR ADVANCED CLEANING SOLUTIONS TO DRIVE THE SEGMENT GROWTH 54
TABLE 10 EXAMPLES OF COMPANIES PROVIDING TECHNOLOGY & INNOVATION IN HEALTHCARE EVS 54
6.5 FRONT-OF-HOUSE CLEANING AND BRAND EXPERIENCE 56
6.5.1 RISING AWARENESS TOWARDS A CLEAN AND SAFE ENVIRONMENT DURING PANDEMICS TO SUSTAIN THE MARKET GROWTH 56
6.6 OTHER SERVICES 56
 
7 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE 57
7.1 INTRODUCTION 58
FIGURE 19 STATES WITH THE HIGHEST NUMBER OF COVID-19 ADMISSIONS
(FEBRUARY 2022) 58
TABLE 11 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE, 2019–2026 (USD MILLION) 59
7.2 ACUTE-CARE FACILITIES 59
TABLE 12 US: HEALTHCARE ENVIRONMENTAL SERVICES FOR ACUTE-CARE SETTINGS, BY TYPE 2019–2026 (USD MILLION) 59
7.2.1 ACUTE HOSPITALS 60
7.2.1.1 Increasing hospital admissions due to COVID-19 and the rising prevalence of HAIs propel the market growth 60
FIGURE 20 NUMBER OF HAIS REPORTED BY GENERAL ACUTE CARE HOSPITALS
IN THE US (2020) 60
FIGURE 21 HAIS REPORTED BY GENERAL ACUTE CARE HOSPITALS IN THE US (2020) 61
FIGURE 22 HAIS REPORTED BY CRITICAL ACCESS HOSPITALS (CAHS) IN THE US (2018) 61
7.2.2 MILITARY TREATMENT FACILITY 61
7.2.2.1 The increasing number of military ambulatory health services & funding to drive the market growth 61
FIGURE 23 MILITARY HEALTH SYSTEMS FACILITIES IN THE US (2021) 62
7.2.3 CHILDREN’S HOSPITALS 62
7.2.3.1 Rising cases of COVID-19 and infection-related mortality rates among children drive the market growth 62
7.2.4 AMBULATORY SURGERY CENTERS (ASCS) 63
7.2.4.1 ASCs save time and reduce the risk of HAIS; key factor driving the market growth 63
FIGURE 24 US SURGERY CASES BY SETTING: ASC VS. HOPD (2005-2020) 64
7.2.5 ACADEMIC MEDICAL CENTERS (AMCS) 64
7.2.5.1 Healthcare capacity expansion during COVID-19 drives the adoption of healthcare environmental services in AMCs 64
7.3 POST-ACUTE CARE FACILITIES 64
TABLE 13 US: HEALTHCARE ENVIRONMENTAL SERVICES FOR POST-ACUTE CARE SETTINGS, BY TYPE 2019–2026 (USD MILLION) 65
7.3.1 LONG-TERM ACUTE HOSPITALS (LTACH) 65
7.3.1.1 Increasing risk of infection due to prolonged hospital stays to drive the market growth 65
7.3.2 SKILLED NURSING FACILITIES (SNF) 66
7.3.2.1 Increasing admissions of elderly people in skilled nursing facilities to drive the market growth 66
7.3.3 OTHER POST-ACUTE CARE FACILITIES 66
7.4 NON-ACUTE CARE FACILITIES 67
TABLE 14 US: ENVIRONMENTAL SERVICES MARKET FOR NON-ACUTE CARE SETTINGS, BY TYPE, 2019–2026 (USD MILLION) 67
7.4.1 PHYSICIAN’S OFFICES AND CLINICS 67
7.4.1.1 High patient traffic leads to continuous cleaning & maintenance to drive the market growth 67
7.4.2 OTHER NON-ACUTE CARE FACILITIES 68
FIGURE 25 DISTRIBUTION OF INDUSTRY MEDICAL AND HEALTH R&D INVESTMENTS,
BY SEGMENT (2020) 68
8 COMPETITIVE LANDSCAPE 70
8.1 OVERVIEW 70
8.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 70
8.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET 71
8.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS 72
8.4 MARKET RANKING ANALYSIS 73
FIGURE 27 US HEALTHCARE ENVIRONMENTAL SERVICE MARKET RANKING,
BY KEY PLAYER, 2020 73
8.5 COMPETITIVE BENCHMARKING 75
TABLE 15 FOOTPRINT OF COMPANIES IN THE HEALTHCARE ENVIRONMENTAL
SERVICES MARKET 75
TABLE 16 SERVICE FOOTPRINT OF COMPANIES 76
TABLE 17 END-USER FOOTPRINT OF COMPANIES 77
8.6 COMPETITIVE LEADERSHIP MAPPING 77
8.6.1 STARS 78
8.6.2 EMERGING LEADERS 78
8.6.3 PERVASIVE PLAYERS 78
8.6.4 PARTICIPANTS 78
FIGURE 28 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET:
COMPETITIVE LEADERSHIP MAPPING (2021) 79
8.7 COMPETITIVE SCENARIO 80
8.7.1 SERVICE APPROVALS/ENHANCEMENTS 80
8.7.2 DEALS 81
TABLE 19 DEALS, 2018–2022 81
8.7.3 OTHER DEVELOPMENTS 82
9 COMPANY PROFILES 83
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
9.1 SODEXO GLOBAL 83
TABLE 21 SODEXO GLOBAL: BUSINESS OVERVIEW 83
FIGURE 29 SODEXO GLOBAL: COMPANY SNAPSHOT (2021) 84
9.2 COMPASS GROUP (CROTHALL HEALTHCARE (US)) 87
TABLE 22 COMPASS GROUP: BUSINESS OVERVIEW 87
FIGURE 30 COMPASS GROUP: COMPANY SNAPSHOT (2021) 88
 
9.3 ARAMARK CORPORATION 90
TABLE 23 ARAMARK CORPORATION: BUSINESS OVERVIEW 90
FIGURE 31 ARAMARK CORPORATION: COMPANY SNAPSHOT (2021) 91
9.4 HOSPITAL HOUSEKEEPING SYSTEMS (HHS) (US) 94
TABLE 24 HOSPITAL HOUSEKEEPING SYSTEMS (HHS): BUSINESS OVERVIEW 94
9.5 HEALTHCARE SERVICES GROUP, INC. 97
TABLE 25 HEALTHCARE SERVICES GROUP, INC.: BUSINESS OVERVIEW 97
FIGURE 32 HEALTHCARE SERVICES GROUP: COMPANY SNAPSHOT (2020) 98
9.6 ABM INDUSTRIES INCORPORATED 100
TABLE 26 ABM INDUSTRIES INCORPORATED: BUSINESS OVERVIEW 100
FIGURE 33 ABM INDUSTRIES INCORPORATED: COMPANY SNAPSHOT (2020) 101
9.7 OCTOCLEAN 103
TABLE 27 OCTOCLEAN: BUSINESS OVERVIEW 103
9.8 SERVICEMASTER CLEAN (SERVICEMASTER TBS) 105
TABLE 28 SERVICEMASTER CLEAN.: BUSINESS OVERVIEW 105
9.9 CORVUS JANITORIAL SYSTEMS 107
TABLE 29 CORVUS JANITORIAL SYSTEMS: BUSINESS OVERVIEW 107
9.10 BRAVO! BUILDING SERVICES 109
TABLE 30 BRAVO! BUILDING SERVICES: BUSINESS OVERVIEW 109
9.11 POWERLINK ENVIRONMENTAL SERVICES, LLC 111
TABLE 31 POWERLINK ENVIRONMENTAL SERVICES, LLC: BUSINESS OVERVIEW 111
9.12 JANI-KING INTERNATIONAL, INC. 112
TABLE 32 JANI- KING INTERNATIONAL, INC: BUSINESS OVERVIEW 112
9.13 AVI FOOD SYSTEMS(US) 114
TABLE 33 AVI FOOD SYTEMS, INC.: BUSINESS OVERVIEW 114
9.14 SERVICON 115
TABLE 34 SERVICON: BUSINESS OVERVIEW 115
9.15 XANITOS, INC. 117
TABLE 35 XANITOS, INC.: BUSINESS OVERVIEW 117
9.16 STATHAKIS 119
TABLE 36 STATHAKIS: BUSINESS OVERVIEW 119
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
10 APPENDIX 120
10.1 INSIGHTS FROM INDUSTRY EXPERTS 120
10.2 DISCUSSION GUIDE 121
10.3 KNOWLEDGESTORE: MARKETSANDMARKETS SUBSCRIPTION PORTAL 124
10.4 AVAILABLE CUSTOMIZATIONS 126
10.5 RELATED REPORTS 126
10.6 AUTHOR DETAILS 127